Abstract. The integrin family of adhesion receptors consists of several heterodimeric glycoproteins, each composed of one a and one/3 subunit. A novel integrin ot subunit partial cDNA isolated from TGF-/3 stimulated guinea pig airway epithelial cells has previously been reported (Erie, D. J., D. Sheppard, J.
T hE integrins are a large family of cell surface glycoproteins that mediate cell-cell and cell-matrix adhesion (21) . All known members of this family are beterodimers consisting of an c~ and a 13 subunit that bind noncovalently to each other. Published reports suggest the existence of 8/3 subunits (/31-/38) (2, 12, 14, 20, 26, 30, 32, 34, 37, 40, 41) and 16 c~ subunits (2-5, 9, 10, 13, 16, 23, 25, 28, 33, 38, 39, 42-47) . 13 of these have been completely sequenced (a 1-or8, c~v, c~M, ctL, aX, txIIb). The existence of aIEL and otLRI has been established on the protein level. We have previously reported identification of partial integrin a subunit cDNA sequences using degenerate oligonucleotide primer pairs and the PCR (13) . Primers were designed based on two highly conserved regions, separated by 72-92-amino acid residues, located within the fifth and sixth repeated domains of the previously reported integrin ot subunits. PCR amplification of eDNA using these primers resulted in the identification of several integrin a subunit partial cDNAs. From guinea pig airway epithelial cells six different sequences were identified. Five of these were 88 to 92% identical to the sequences of cd-ot3, a5 and c~v from was isolated using the LiCl/Urea method (12) . Single-stranded cDNA was synthesized at 44°C for 1 h from 1 to 5/~g of mRNA or 20-40/~g of total RNA using the Superscript cDNA Synthesis System (GIBCO-BRL, Galthersburg, MD) and random DNA hexamers. In some cases cDNA was synthesized as above using a previously described sequence tagged random DNA hexamer primer (CGA~ATGGTCGACGGAAGCGACC-NNNNNNT) (15) .
Amplification and Purification of Lambda Library DNA
Aliquots of Xgtl 1 libraries containing 1-5 million plaque forming units were mixed with 500 #1 of LE392 bacteria (OD = 0.5) in SM buffer (100 mM NaC1, 8 mM MgSO4, 50 mM Tris-HC1, pH 7.0, 0.01% gelatin), incubated 15 rain at 37°C, and shaken at 250 rpm overnight at 37°C in Luria broth containing 10 mM MgC12 and 0.2% maltose. The cultures were incubated at 37°C and 250 rpm for 30 min with 5% chloroform. Aliquots of the aqueous layer were subjected to three cycles of 3 min in dry ice/ethanol followed by 3 rain at 90°C, phenol/chloroform extraction, and precipitation with ethanol.
PCR Amplification
PCR reactions were performed in 25-200/~1 reaction volumes and conrained 1 × Taq buffer (Promega, Corp., Madison, WI) with 1.5 mM MgCI2, 0.1/~M each of two primers, 0.025 U/pl Taq Polymerase (Promega Corp.), 1-8/~1 of DNA template, and 0.1 mM each of dATP, dGTP, dCTE and dTTP. Reactions were heated to 94°C for 4 rain in a thermocycler (ElUCOMP, Inc., San Diego, CA) and then subjected to 30 cycles of PCR followed by 10 rain at 72°C. Reactions that contained degenerate oligonncleotide primers were subjected to PCR cycles consisting of 45 s at 94°C, 45 s at 48 or 53 °C, and 45 s at 72°C. Reactions that contained cO-specific primer pairs designed to amplify DNA fragments less than 750 nucleotides were subjected to PCR cycles consisting of 45 s at 94°C, 45 s at 57°C, and 60 s at 72°C. Reactions that contained an cO-specific primer, a Xgtll-specific primer CAgtllF: CCTCCGTCGA~GGTGC~GACGACTC~CCG or ~tlLR: CCTCCGTC~~CAACTGGTAATG), and purified concentrated total library DNA were subjected to PCR cycles consisting of 45 s at 94°C, 45 s at 60°C, and 120 s at 72°C. All other PCR reactions were subjected to cycles consisting of 45 s at 94°C, 45 s at 570C, and 120 s at 72°C. Products of each PCR reaction were analyzed by agarose gel electrophoresis using standard or low gel temperature agarose.
PCR reactions designed to amplify 3' sequence from sequence tagged cDNA, described above, contained r,9-specific forward primers and primers complementary to the sequence tagged random hexamer (GAT-GGTCGACGGAAGCGAAC or CGA~ATGGTCGACGG) and were performed as above.
Cloning of DNA Fragments
Restriction-digested DNA fragments were isolated on low gel temperature agarose and purified by phenol/chloroform extraction and ethanol precipitation. Fragments were ligated into restriction-digested, dephosphorylated pBluescript vector (Stratagene, La Joila, CA) with T4 DNA ligase (GIBCO-BRL). The ligation mixture was used to transform competent Escherichia coli (JM-109; Clontech, Palo Alto, CA). Selected plasmids were purified from liquid cultures using the Pharmacia miniprep lysis kit (Pharmacia Fine Chemicals/LKB, Pleasant Hill, CA) and sequenced using Sequenase 2.0 (United States Biochemical Corporation, Cleveland, OH), 35S-dATP (Amersham Corp., Arlington Heights, IL), T3 primer, T7 primer, and a variety of primers specific for c~9.
Library Screening
Partial cDNA fragments were used as templates for the random-primed synthesis of [32p]dCTP-labeled probes (multiprime DNA labeling system; Amersham Corp.). These probes were used to screen an oligo-dT-primed Xgtl I cDNA library from human lung tissue including trachea and bronchioles (catalog No. HL 1066b; Clontech) and a mixed random and oligo-dT primed Xgtll cDNA library from human small intestine tissue (catalog No. HLlI33b; Clontech). Hybridizations were performed at 50°C for 16 h in hybridization buffer (40% formamide, 50 mM sodium phosphate, pH 6.5, 800 mM NaCI, 0.05% polyvinylpyrrolidone, 0.05% BSA, 0.05% ficoll, 1 mM EDTA, 0.1% SDS, and 10 ng/mi heat-denatured, sonicated salmon sperm DNA). Filters were washed twice in 1x SSC containing 0.1% SDS for 5 min at room temperature, and once in 0.5× SSC containing 0.1% SDS for 1 h at 50°C and exposed to film for 18 h at -80°C with intensifying screens. Positive library clones were isolated by further rounds of screening, and the inserts were isolated either by PCR amplification using ~gtll-specific primers or by EcoRI digestion of purified phage DNA. The inserts were then subcloned into EcoRI-digested pBluescript and sequenced.
Northern Blot Analysis
Total cellular RNA was electrophoresed through a formamide-agarose gel and transferred to a nylon membrane (Hybond-N; Amersham Corp.). Radiolabeled probe was synthesized from 2.1 kb of CO sequence using the Mnitiprime Labeling System (Amersham Corp.) and [32p]dCTP. Filters were incubated at 50°C for 16 h in hybridization buffer containing 5 × SSC, 40% formamide, 20 mM Tris, pH 7.5, 0.1% polyvinylpyrrolidone, 0.1% BSA, 0.1% flcoll, 10% dextran sulfate, and 100/tg/mi heat-denatured, sonicated salmon sperm DNA, and washed in 5x SSC containing 0.1% SDS at 50°C for 30 rain. After washing, filters were exposed to film at -80°C with an intensifying screen.
Antibodies and Immunoprecipitations
Polyclonal antiserum was generated against the cO peptide CRKENEDSW-DWVQKQ. Peptide synthesis, conjugation to KLH, and injection of rabbits was performed by Immunodynamics, Inc. (La Jolla, CA). cO antibodies were affinity purified from crude antiserum on a peptide-lysozyme-Affigel column as follows. Affigel-10 slurry (4-ml bed volume) (Bio Pad Labs., Richmond, CA) was washed three times with cold 10 mM sodium a~etate, pH 4.5; rinsed once with 0.1 M potassium phosphate, pH 7.5; mixed with 100 rag lysozyme (Sigma Immunochemicals, St. Louis, MO) in 8 ml 0.1 M potassium phosphate, pH 7.5, for 2 h at room temperature; washed twice with 0.1 M potassium phosphate, pH 7.5; mixed with 8 ml 0.2 M ethanolamine, pH 8.0, for 2 h at room temperature; and washed three times with PBS. Lysozyme-Affigel (600-~1 bed volume) was washed with 0.05 M sodium phosphate, pH 8.0; mixed with 2. mAb P5D2 (11) directed against the/31 integrin subunit was a gift from Elizabeth Wayner (University of Minnesota, Minneapolis, MN). mAb RtCO directed against the 86 integrin subunit was generated in our laboratory. For some experiments antibodies were cross linked to protein A-Sepharose with dimethylpimelimidate (17) .
Cells were surface labeled with [~25I], lysed in immunoprecipitation buffer (100 mM Tris-HCl, pH 7.5, 0.1% SDS, 1% Triton X-100, 0.1% NP-40, and 300 mM NaCl), and immunoprecipitated by standard techniques. Samples were analyzed by SDS-PAGE on 7.5% acrylamide gels and exposed to film at -80°C with intensifying screens.
~ssue Staining
Frozen sections (5 ~m) of tissue were fixed in either 2 % paraformaldehyde (mouse tissue) at room temperature or in -18°C acetone (human tissue) for 5 rain and subsequently rinsed in PBS. Sections were blocked for endogenous pemxidase activity with Peroxoblock Solution (Zymed Laboratories, Inc., South San Francisco, CA) for 45 s at room temperature. After rinsing, sections were preblocked with 0.5% casein/0.05% thimerosal/PBS for 15 rain at room temperature and then incubated overnight at 4°C in primary antibody (1:200 in 0.5% casein/0.05% thimemsal/PBS) that either was or was not preincubated with 0.1 mg/mi cO peptide for 30 rain at 4°C. After rinsing in PBS, sections were incubated in either biotinylated donkey anti-rabbit secondary antibody (Amersham Corp.) at a dilution of 1:200 or peroxidase-conjngated goat anti-rabbit secondary antibody (Vector Laboratories, Burlingame, CA) at a dilution of 1:250 for 1 h at room temperature in 0.5 % casein/0.05 % thimerosal/PBS. Sections incubated with biotinylated secondary antibodies were then rinsed and incubated in ABC avidin/pemxidase reagent (Vector Laboratories) for 1 h at room temperature. Chromagen was developed using the DAB Plus Kit from Zymed Laboratories. Reactions were monitored until suitable color development was achieved. The signal was enhanced with 0.5% nickel chloride, and the sections were rinsed in distilled water. Sections were subsequently air dried and then mounted with Permount (Fisher Scientific, Pittsburgh, PA) onto clean slides.
Protein Sequencing
Human uterine tissue was homogenized in immunoprecipitation buffer and cleared by centrifugation at 200 g. The supernatant was incubated with afffinity-purified t~9 anti-cytoplasmic peptide antiserum cross-linked to prorein A-Sepharose CIAB (Pharrnacia Fine Chemicals, Piscataway, NJ) overnight at 40C. The beads were then washed extensively with immunoprecipitation buffer and heated to 95"C for 5 rain in 2% SDS, 300 mM 2-mercaptoethanol, 80 mM Tris, pH 6.8. The supernatant was concentrated on a Centricon-10 Concentrator (Amicon, Beverly, MA), subjected to 7.5 % SDS-PAGE, transferred to PVDF membrane (Bio Rad Labs. Hercules, CA) for 3 h at 50 V in 10 mM 3-(cyclohexylamino)-l-propanesulfonic acid, pH 11/10% methanol, and quantified by staining with 0.1% Coomassie blue R-250 in 40% methanol/l% acetic acid. A prominent band at 150 kD was microsequenced by the USCF Biomedical Resource Center (San Francisco, CA).
Results

Cloning and Sequencing of Human ~9
A novel 223-nucleotide partial guinea pig integrin c~ subunit cDNA (t~A) was previously reported by Erie et al. (13) . To obtain the corresponding human sequence of the novel subunit, we used the previously described degenerate integrin a subunit forward primer (A14F: CGGAATTCGGIG-
A(AG)CAG(AC)TIG(CG)I-(GT)CIGA(CT)TT(CT)GG), a degenerate reverse primer based on the t~ sequence (AN2R: CAAGTCGACAA(AG)TGIGC(AG)TT(GC)TA-IGCIC(GT)(AG)TC)
, and eDNA made from human lung tissue. A band of the predicted size (204 nueleotides) was obtained (data not shown), subcloned into pBluescript, and sequenced. The resulting nucleotide sequence was 88% identical to the sequence of guinea pig ou~ and 39-54% identical to other known human integrin a subunits. For reasons discussed later, we have named this novel human integrin subunit or9.
The 204-nueleotide or9 cDNA fragment was used to screen a human lung eDNA library. One hybridizing clone, L1 ( Fig. 1 ), was identified, purified, subcloned and sequenced. This 1,678-bp clone contained a 1,123-nucleotide open reading frame that included the probe sequence.
We were able to amplify a9 from cDNA from leukocyte cell lines U937 (clones U1-U3) and HL-60 (I41) by PCR using ot9-specific primers. To isolate additional sequence from these cell lines, we used a previously described 3'-sequence extension technique (15) which employs PCR. One clone from HL-60 eDNA, H2, and one clone from U937 cDNA, U4, obtained by this method contained 117 nucleotides of a9 sequence.
PCR was performed on amplified purified human lung cDNA library DNA using ot9-specific forward oligonucleotide primers and hgtl 1-specific primers (hgtl 1F and hgtl 1R). Individual bands were isolated, reamplified, subcloned, and sequenced. One clone, L2a, consisted of 300 nucleotides of ~9 sequence. Clone L2a was used as a probe for screening the human lung library and one hybridizing clone, L2b, was isolated, purified, subcloned, and sequenced. Both clone L2a and clone L2b ended at nucleotide 1817, suggesting that clones L2a and L2b represented the same library clone.
Figure L Clones labeled 77-T3 were obtained by PCR from Tera-2 eDNA. The direction and extent of sequencing are indicated with arrows. All reported sequence was sequenced completely in both directions from at least two independent clones. Noncoding sequences found on the 5' end of clones L/(555 bp), D3 (108 bp), and D6 ('~1200 bp) are not indicated on the map.
We screened a human duodenal cDNA library with probes from clones L1 and L2. 12 independent hybridizing clones were identified, isolated, subcloned, and analyzed. Six of these were determined to contain additional or9 cDNA and were sequenced (D1-D6). D2 and D6 contained a predicted transmembrane domain, cytoplasmic domain, and translation stop codon. D6 also had an additional 1.1 kb, 3' of the stop codon, which did not extend to the poly(A) tail.
To complete the or9 sequence, a9 protein was purified from human uterus using anti-or9 antiserum, described later, and microsequenced. The amino terminal sequence was equivocally determined to be YNLD(T/P)(Q/E). A series of degenerate forward oligonucleotide PCR primers were designed based upon these possible amino-terminal sequences. PCR amplifications were performed using each of the degenerate forward primers paired with ot9-specific reverse oligonucleotide primers and Tera-2 eDNA (data not shown). Reactions using a degenerate forward primer based upon the sequence YNLDPQ and two different t~9-specific reverse primers resulted in intense bands which were cloned and sequenced (T1-T3).
We have sequenced 3,139 nucleotides ( Fig. 2 ) of a9 eDNA that contains a 3,000-nucleotide open reading frame that includes a termination signal but lacks an initiation codon. Based on this cDNA sequence and the amino terminal sequence we obtained, we predict the mature tx9 protein to be 1,006 amino acids in length with a 947-amino acid extracellular domain, a 26-amino acid transmembrane domain, and 
The Relationship of a9 to Other Integrin c~ Subunits
Comparison of cx9 to the general structure of integrin o~ subunits is indicated in Fig. 3 age near the transmembrane domain. The second subfamily includes the five oz subunits that contain an I domain. The third subfamily consists of or4, which contains neither the I domain nor undergoes cleavage yielding disulfide-linked fragments. The deduced partial amino acid sequence of oD is 39% identical to the integrin or4 subunit sequence and 18-22% identical to the other known human integrin o~ subunit sequences. Based on its sequence and structural similarity to oz4, a9 is clearly a member of the third integrin cx subunit subfamily. Fig. 4 shows the alignment of the predicted cz9 amino acid sequence with c~4. All 23 cysteine residues found in oz9 align with those found in oz4 (o~4 contains one additional cysteine), including the 19 cysteines generally found in integrin ot subunits. , 4 contains a cleavage site following Lys557-Arg558 which is absent in o~9.
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~9 Is Expressed by Teratoma and Colon Carcinoma Cells and Forms a Heterodimer with [31
To demonstrate expression of or9 mRNA and to identify cell lines that express otg, Northern blots were performed. Total RNA was isolated from a variety of cell lines and analyzed by Northern blotting with a 2.1-kb a9 eDNA probe (Fig. 5 ). This probe hybridized with an ,~7.0-kb mRNA band (size markers not shown) that was present in two of the cell lines tested, i.e., Tera-2, and Caco-2 cells (lanes 1 and 2) . The smaller band may represent partially degraded a9 mRNA. Alternatively, a second or9 mRNA species derived by alternative splicing or an alternative polyadenylation signal may be present in these cells. Tera-2 cells are derived from an embryonal carcinoma, and Caco-2 cells from a colon carci- Figure 6 . Alignment of integrin c¢ suhunit cytoplasmic domains.
The COOH-terminal cytoplasmic sequences of the known human integrin c~ subunits are shown (references 2, 5, 9, 10, 28, 33, 39, 42-45). The amino acid sequence of the peptide used for production of otg-specific rabbit antiserum is underlined and labeled a9
Peptide.
noma. The carcinoma-derived cell line HeLa 0ane 3) and the leukocyte-derived cell lines Raji, HuT 78, MOLT-4, and HL-60 (lanes 4--7) were negative for expression of or9, as were cell lines U937 (histiocytic lymphoma), K-562 (chronic myelogenous leukemia), Daudi (Burkitt's lymphoma), AN3CA (endometrial carcinoma), and JEG-3 (choriocarcinoma) (data not shown).
The sequences of the cytoplasmic domains of the known vertebrate integrin o~ subunits are shown in Fig. 6 . It is evident that the or9 cytoplasmic domain is distinct from all other subunits, except for very limited similarity to the c~4 cytoplasmic domain. A 15-amino acid oL9 peptide (underlined in Fig. 6 ) with an additional cysteine residue at the NH2 terminus was used to generate polyclonal rabbit antiserum which was subsequently affinity purified on the same peptide coupled to Sepharose. The sequence of this peptide is distinct from the cytoplasmic domain sequences of the other a subunits, except for a three-amino acid identity (DSW) with or4. Cross-reactivity of the anti-or9 peptide serum with or4 or any other known ot subunit is unlikely.
Immunoprecipitations were performed on surface labeled Tera-2 lysate with a9 antiserum or with a MAb against the integrin [31 subunit. The immunoprecipitates were analyzed by SDS-PAGE under reducing and nonreducing conditions (Fig. 7) . Immunoprecipitation with anti-B1 yielded major Figure 7 . Immunoprecipitation of oD-and/~l-containing integrins from lysates of Tera-2 cells. Aliquots of 125I-surface-labeled lysates from Tera-2 cells were immunoprecipitated with a monoclonal anti-ill antibody (lanes 1 and 4), affinity purified polyclonal antiserum raised against a portion of the cytoplasmic domain of a9 (lanes 2 and 5), and preimmune serum (lanes 3 and 6). The proteins were analyzed by SDS-PAGE under nonreducing (lanes 1-3) and reducing (lanes 4-6) conditions followed by autoradiography. The positions of molecular size markers (in kD) are shown to the right• 10-fold less lysate was used in the B1 immunoprecipitation than in the cO or preimmune serum immunoprecipitations. Figure 8 . Immunodepletion of /~1 containing integrins. Aliquots of 125I-surface-labeled lysates from Tera-2 cells were subjected to four rounds of immunoprecipitation with an anti-/~l monoelonal antibody or an anti-/~6 mAb crosslinked to protein A-Sepharose. The resulting supernatants were immunoprecipitated with affinity purified tx9 polyclonal antiserum. The immunoprecipitated material (anti-/31 first round immunoprecipitate, lane 1; anti-/31 followed by a9 antiserum, lane 2; anti-B6 followed by tx9 antiserum, lane 3) was analyzed by SDS-PAGE under nonreducing conditions followed by autoradiography. The positions of molecular size markers (in kD) are shown to the right. (19) . The lower band migrated with the same apparent molecular mass as/31 (19) . The band present in c~9 immunoprecipitations at 110 kD is also present in immunoprecipitations using preimmune serum (lanes 3 and 6), and hence is nonspecific.
To determine if/51 was a/3 subunit partner for or9, Tera-2 lysates were subjected to four rounds of immunodepletion with either anti-Bl or anti-/56 antibody followed by immunoprecipitation with affinity purified o~9 antiserum. The results (Fig. 8) show that o~9 could not be immunoprecipitated from lysate depleted of/51 (lane 2). Immunodepletion with the anti-/56 antibody (lane 3) did not interfere with subsequent precipitation of o~9, demonstrating that nonspecific loss of o~9 does not occur during multiple rounds of immunodeplefion. These results suggest that/51 is the predominant/3 subunit partner for ct9 in Tera-2 cells. This justifies our terminology, following the convention of sequentially numbering the tx subunit partners of/51.
~9 Is Widely Distributed in Normal Tissues
Because or9 was initially isolated from airway epithelial cell eDNA, we attempted to identify a9 in human airway tissue by immunohistochemistry. Fig. 9 A, shows a human airway biopsy section, including epithelium and submucosa, stained with hematoxylin, or9 antiserum intensely stained the airway epithelium (B). When the antiserum was incubated with oD peptide prior to tissue staining, staining of the epithelium was substantially blocked (C).
Because we were able to detect •9 immunoreactivity in airway tissue, we examined the expression of oO in other tissues. Sections of mouse tissue were stained with hematoxylin (Fig. 9, D , G, and J) oO antiserum (E, H, and K), or c~9 antiserum preblocked with o6) peptide (F, I, and L). In mouse esophagus (D-F), the basal layer of the epithelium (arrow) was stained by -9 antiserum. Skeletal muscle (M) present in this section also showed oD immunoreactivity. In mouse small intestine (G-l) both the longitudinal and circumferential smooth muscle layers (SM) reacted with the oD antiserum. Hepatocytes in the liver (J, K, and L) demonstrate cell surface localiTation of ¢x9. A variety of other mouse tissues were analyzed for the presence of oO. Table I summarizes these results. The tracheal epithelium; basal epithelium of the larynx, pharynx, esophagus, skin, and cornea; smooth muscle of trachea, veins, duodenum, colon, stomach, and esophagus; skeletal muscle; hepatocytes; and splenic giant cells all demonstrated or9 immunoreactivity. In all of these cases, staining was blocked by incubation of the o~9 antisenun with , 9 peptide prior to tissue staining.
Discussion
This report presents three novel findings. First, we present the complete amino acid sequence, deduced from eDNA and amino terminal sequencing, of a new member of the human integrin o~ suhunit family, ¢x9. Second, we demonstrate that oD forms an integfin heterodimer with the known [3 subunit, /31. Third, we show that oD is expressed in a variety of cell types in vivo including airway epithelial cells, the basal layers of squamous epithelium, smooth muscle, skeletal muscle, and hepatocytes.
Comparison of the deduced amino acid sequence of oD with the previously published sequences of human integrin ot subunits clearly demonstrates that this protein is a member of the integrin ¢x subunit family, or9 has high sequence homology with other human integrin ¢x subunits and has predicted structural features common to the intcgrin ot subunits including (a) a large extracellular domain containing four partial and three complete metal binding domains, 19 consensus cysteine residues, and several potential N-glycosylation sites, (b) a single transmembrane spanning domain, and (c) a short cytoplasmic domain containing the sequence GFF(K/R)R. Although oD is the only human integrin ot subunit to have the alternative sequence GFFRR, chicken or3 contains GFFRR (22) . Both variations of this sequence are also found in the DNA binding domain of the members of the steroid hormone receptor superfamily (29) . The functional significance of this sequence is not known, although it has been reported that a GFFKR-containing peptide can interact with the Ro/SS-A antigen (calreticulin) (35) .
There are reports of four other integrin, subunits for which the human sequence has not been published. We do not believe that any of these four are identical to the subunit we describe based on the following evidence. The integrin subunits or7 and oL8 have been cloned from other species, and the resulting sequences have less than 21% amino acid identity to or9 (4, 38) . Partial eDNA sequences of the human homologs of a7 and t~8 are clearly distinct from the or9 sequence (our unpublished observations). Both of the subunits of a novel integrin expressed on activated leukocytes, termed the leukocyte response integrin, have different electrophoretie mobilities than does c~9 (16) . The previously identified HML-1 antigen is an integrin composed of a novel ot subunit, oriEL, paired with/5'/ (7, 25, 47) . The HML-1 antigen has been detected in intraepithelial lymphocytes and a subset of lymphocytes located in the submucosal layer of the intestine (8), whereas ct9 was not detected in either the intestinal epithelial layer or submucosa.
We screened several cell lines by Northern blotting for expression of or9 and identified two cell lines, Tera-2 and Caco-2, that expressed significant levels of ct9 mRNA. Immunoprecipitation of lysates from these cell lines with ct9 anti-peptide antiserum precipitated a heterodimer consisting of a larger subunit of similar size to many other u subunits and a smaller subunit that eomigrated with/31 (Caco-2 data not shown). Immunodepletion of/31 from Tera-2 lysates removed all detectable et9 irnmunoreactivity, suggesting that /31 is the principal/3 subunit partner for or9 in these cells. This increases the number of ot subunits known to associate with/~1 to 10. Three of these ct subunits (c~v, et4, and ct6) can also form heterodimers with other/3 subunits. We cannot exclude the possibility that or9 is expressed in low abundance with another/3 subunit in Tera-2 cells or that c~9 has other /3 subunit partners in other cell lines or in vivo.
The closest known relative of the c~9 subunit is the c~4 subunit, or9 and et4 share 39 % amino acid identity and are both equally divergent from the other known c¢ subunits. Consistent with their similarity, c~9, like or4, is not composed of two disulfide-linked fragments and does not contain an I domain. Integrin ot subunits generally demonstrate low correlation of sequence similarity with tissue distribution. Therefore, even though a9 and et4 are closely related, we would not necessarily expect them to have similar expression patterns. ~4 was first identified on leukocytes (19) and has more recently been shown to be expressed on endothelial cells (31) and in developing, but not adult, skeletal muscle (36) . In contrast, ~9 was detected in adult skeletal and smooth muscle and in a subset of epithelial cells and is not generally expressed in lymphocytes or in endothelium. Although or9 was detected by PCR in two leukocyte cell lines, it could not be detected by Northern blotting in these ceils. The overwhelming majority of lymphocytes present in sections of mouse spleen did not stain with the a9 antibody. However, rare, splenic giant cells did demonstrate or9 immunoreactivity, suggesting that a9 may be expressed in at least some leukocytes in vivo.
Our results show widespread expression of or9 in vivo. In airway epithelium and the basal layer of squarnous epithelium, a9 appears to be distributed at cell-cell borders as well as at cellular contacts with basement membrane. In smooth muscle, skeletal muscle, and hepatocytes, oD appears to be uniformly distributed over the cell surface. In these tissues, a9 is expressed diffusely at sites of homotypic cell to cell contact in ceils that are not actively involved in spreading, migration, or any other obvious dynamic interaction with the extraceUular matrix. These results suggest that or9 may be involved in homotypic cell-ceil interactions. Although integrins are not generally thought to be involved in homotypic cell-cell adhesion in non-leukocyte ceils, localization of integrins to cell-cell contacts has been shown for c~2fll in bronchial epithelial cells (1) , cultured keratinocytes (6), and endothelial ceils (27) ; for t~3/31 in bronchial epithelial cells (1) , cultured keratinocytes (6) , and a variety of transformed cell lines (24) ; and for ot5/31 in endothelial cells (27) . Furthermore, contacts between cultured keratinocytes have been shown to be disrupted by antibodies directed against ot3/31 and 131 (6) . Mediation of cellular cohesion by integrins could result from direct binding of integrins to counter-receptors present on adjacent cells or by neighboring cells jointly binding to extracellular matrix proteins deposited in the intercellular space.
The results of this study demonstrate the existence of a previously unrecognized member of the integrin family that is widely expressed in vivo in differentiated cells that are not actively involved in migration, proliferation, or heterotypic interactions with other cells. These data suggest that this integrin may function in some aspect of normal tissue cohesion or homeostasis. More definitive functional characterization will require identification of the ligand or ligands for this receptor and the development of reagents that specifically interfere with its function.
